Clinical Trial Update: Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer [NA]

View source ↗

Summary

A clinical trial update evaluating imaging characteristics of different Gallium-68 PSMA PET probes in prostate cancer. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA imaging probe (unspecified) (Gallium-68 labeled PSMA ligand)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING